Dexcom Stock Plunges Despite Q3 Beat But Retail Sentiment Improves
DexCom has made progress with turning things around although top-line growth leaves much to be desired, an analyst said following the glucose monitoring equipment maker’s Q3 results. Dexcom, Inc. ($DXCM)…